IP Library Granted Patent US 7,763,033
Granted Patent B2
US 7,763,033 · App. 11/852,116 · Granted Jul 27, 2010

System and methods for preventing intravasation during intrauterine procedures

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,763,033
App. No.
11/852,116
Granted
Jul 27, 2010
Kind
B2
Abstract

Systems, methods, apparatus and devices for performing improved gynecologic and urologic procedures are disclosed. Patient benefit is achieved through improved outcomes, reduced pain, especially peri-procedural pain, and reduced recovery times. The various embodiments enable procedures to be performed outside the hospital setting, such as in a doctor's office or clinic. Distension is achieved mechanically, rather than with liquid distension media, thereby eliminating the risk of intravasation.

Claims (39)

1. A method of preventing intravasation during an intrauterine procedure, comprising the steps of:

transcervically accessing the uterus with an elongate tubular sheath;

introducing a mechanical distension device through the sheath and into the uterus, while the mechanical distension device is in a retracted state;

distending the uterus by expanding the mechanical distension device from the retracted state into an expanded state so as to distend the uterus and expose a site;

introducing a surgical device while the mechanical distension device remains within the uterus in the expanded state; and

performing a surgical procedure at the site with the surgical device and with the mechanical distension device in the expanded state within the uterus,

wherein the mechanical distension device comprises an inflatable device, wherein the step of introducing the mechanical distension device into the uterus while the mechanical distension device is in a refracted state comprises introducing the mechanical distension device into the uterus with the inflatable device in a deflated state.

2. A method of preventing intravasation during an intrauterine procedure as in claim 1 , wherein the transcervically accessing step comprises advancing the sheath over a guidewire.

3. A method of preventing intravasation during an intrauterine procedure as in claim 1 , wherein the transcervically accessing step is accomplished under local anesthesia.

4. A method of preventing intravasation during an intrauterine procedure as in claim 1 , wherein the distending step achieves an equivalent distension to that achieved by introduction of a liquid distension media at a pressure of at least 40 mm Hg.

5. A method of preventing intravasation during an intrauterine procedure as in claim 1 , wherein the distending step achieves an equivalent distension to that achieved by introduction of a liquid distension media at a pressure of about 70 mm Hg.

6. A method of preventing intravasation during an intrauterine procedure as in claim 1 , further comprising the step of dilating the cervix prior to the transcervically accessing step.

7. A method of preventing intravasation during an intrauterine procedure as in claim 1 , wherein the performing a procedure step comprises treating a uterine fibroid.

8. A method of preventing intravasation during an intrauterine procedure as in claim 1 , wherein the step of distending the uterus comprises inflating the inflatable device.

9. A method of preventing intravasation during an intrauterine procedure as in claim 1 , wherein the performing a procedure step comprises performing a diagnostic procedure.

10. A method of preventing intravasation during an intrauterine procedure, comprising the steps of:

transcervically accessing the uterus with an elongate tubular sheath;

introducing a mechanical distension device through the sheath and into the uterus, while the mechanical distension device is in a retracted state;

distending the uterus by expanding the mechanical distension device from the retracted state into an expanded state so as to distend the uterus and expose a site;

introducing a surgical device while the mechanical distension device remains within the uterus in the expanded state; and

performing a surgical procedure at the site with the surgical device and with the mechanical distension device in the expanded state within the uterus,

wherein the mechanical distension device comprises an expandable basket, wherein the step of introducing the mechanical distension device into the uterus while the mechanical distension device is in a refracted state comprises introducing the expandable basket into the uterus with the expandable basket in a collapsed state.

11. A method of preventing intravasation during an intrauterine procedure as in claim 10 , wherein the step of distending the uterus comprises deploying the expandable basket.

12. A method of preventing intravasation during an intrauterine procedure as in claim 10 , wherein the transcervically accessing step is accomplished under local anesthesia.

13. A method of preventing intravasation during an intrauterine procedure as in claim 10 , wherein the distending step achieves an equivalent distension to that achieved by introduction of a liquid distension media at a pressure of at least 40 mm Hg.

14. A method of preventing intravasation during an intrauterine procedure as in claim 10 , further comprising the step of dilating the cervix prior to the transcervically accessing step.

15. A method of preventing intravasation during an intrauterine procedure as in claim 10 , wherein the performing a procedure step comprises treating a uterine fibroid.

16. A method of preventing intravasation during an intrauterine procedure as in claim 10 , wherein the performing a procedure step comprises performing a diagnostic procedure.

17. A method of performing a procedure in the uterus, comprising the steps of:

transcervically accessing the uterus with an elongate flexible tubular sheath, having a proximal end, a distal end and at least one lumen extending therethrough, the sheath having an outside diameter of no more than about 9 mm;

introducing a mechanical distension device through the sheath and into the uterus with the mechanical distension device in a retracted state;

distending the uterus by expanding the mechanical distension device from the retracted state into an expanded state, and thereby exposing a site;

introducing a visualization device through the sheath, to visualize the site, while the distension device remains in the uterus in the expanded state;

introducing a surgical device through the sheath and into the uterus while the distension device remains in the uterus and in the expanded state; and

performing a surgical procedure at the site with the surgical device and with the mechanical distension device in the expanded state within the uterus,

wherein the mechanical distension device comprises an expandable basket, wherein the step of introducing the mechanical distension device into the uterus while the mechanical distension device is in a refracted state comprises introducing the expandable basket into the uterus with the expandable basket in a collapsed state.

18. A method of preventing intravasation during an intrauterine procedure as in claim 17 , wherein the step of distending the uterus comprises deploying the expandable basket.

19. A method of performing a procedure in the uterus as in claim 17 , wherein the method is a diagnostic method.

20. A method of performing a procedure in the uterus as in claim 17 , wherein the method is a treatment for a uterine fibroid.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO BIOLUCENT, LLC; CYTYC SURGICAL PRODUCTS, LLC, AS SUCCESSOR-BY-CONVERSION TO CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; GEN-PROBE INCORPORATED, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.
Reel/Frame 075566/0039 →
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 035820 FRAME: 0239. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST RELEASE. Recorded Nov 9, 2017
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 044727/0529 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 028810 FRAME: 0745. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Nov 9, 2017
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 044432/0565 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE REEL/FRAME 028810/0745 Recorded Jun 4, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 035820/0239 →
SECURITY AGREEMENT Recorded Aug 1, 2012
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 028810/0745 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 18, 2011
From: INTERLACE MEDICAL, INC.
To: HOLOGIC, INC.
Reel/Frame 025835/0684 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 8, 2007
From: GRUBER, WILLIAM H.; ADAMS, RONALD D.; CONNORS, KEVIN G.; PARDO, GEOFFREY B.; COLE, JAMES DANIEL; FLAHERTY, J. CHRISTOPHER
To: INTERLACE MEDICAL, INC.
Reel/Frame 020097/0888 →